跳至主要内容
临床试验/NCT01392118
NCT01392118Unknown不适用

Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change

Chang Gung Memorial Hospital1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
400
试验地点
1

研究概览

简要总结

The purpose of this study is to investigate the risk factor, molecular character and susceptibility change for recurrent ESBL-producing Enterobacteriaceae bacteremia

详细描述

  1. To characterize the genotypes of the pathogens isolated from recurrent ESBL-EK bacteremia versus non-recurrent ESBL-EK bacteremia to differentiate relapse from reinfection
  • recurrent versus non-recurrent
  • relapse versus reinfection
  1. To correlate the patient characteristics, clinical manifestations, severity of illness (the modified Pitt bacteremia score), diagnosis of deep-site infection, co-morbid conditions (including diabetes mellitus, hepatic and renal dysfunction), length of stay in ICU/hospitalization, the presence of invasive procedures, source of pathogen (community acquired or nosocomial infection), antimicrobial regimen (i.e carbapenems versus non-carbapenems(flomoxef or quinolones), microbiological characteristics (E coli and Kleb. pneumoniae) and outcome endpoints (clinical outcome and mortality) with ESBL recurrence and genotypes

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (age>=18 years) with at least one episode of ESBL-EK bloodstream infection from August 2004 to July 2010

排除标准

  • Patients who died within 48h after first episode of ESBL-EK bloodstream infection

研究者

发起方
Chang Gung Memorial Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Recurrent ESBL-producing Enterobacteriaceae... | 临床试验